Laura Garcia E. Vasconcelos

Laura Garcia E. Vasconcelos

Auto-generated profile, based on publicly available information

Laura Garcia E. Vasconcelos

Department of Otorhinolaryngology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2022 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
PSPatricia Simonetti
Patricia Simonetti
LVLaura Garcia Vasconcelos
Laura Garcia Vasconcelos
MGMara Rocha Gândara
Mara Rocha Gândara
KMKarina Lezirovitz Mandelbaum
Karina Lezirovitz Mandelbaum
ÍMÍtalo Roberto Torres de Medeiros
Ítalo Roberto Torres de Medeiros
JOJeanne Oiticica
Jeanne Oiticica
Our study aimed to measure the effectiveness of using HA in reducing the disturbance caused by tinnitus. Study was designed as a within-subjects clinical trial. Nineteen patients with chronic tinnitus and untreated sensorineural hearing loss were under counseling, HA fitting and 6 months follow-up. Tinnitus assessment was performed with Tinnitus Handicap Inventory (THI), Visual Analog Scale (VAS), pitch and loudness matching, and Minimum Masking Level measurements (MML). following 6 months of HA use, a reduction in reported tinnitus and hearing handicap scales scores was observed both statistically and clinically. The pitch and loudness matching, as well as MML at the baseline and final evaluation were compared. MML’s thresholds reduced significantly after 6 months of HA use. Our study has provided evidence that HA fitting is a valuable treatment strategy for chronic tinnitus relief and associated hearing loss subtype of patient. 3.

30 August 2021 in International Archives of Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
CCCarla Alexandra Campagna
Carla Alexandra Campagna
JAJuliana Anauate
Juliana Anauate
LVLaura Garcia E. Vasconœlos
Laura Garcia E. Vasconœlos
JOJeanne Oiticica
Jeanne Oiticica
Introduction Therapeutic dry needling (DN) is effective in reducing the discomfort of chronic somatosensory tinnitus in patients with myofascial trigger points (MTP)s. Objective To evaluate the efficacy of DN in chronic somatosensory tinnitus discomfort in patients with MTP. Methods Placebo-controlled paired trial that included 16 patients with a diagnosis of somatosensory chronic tinnitus and with the presence of at least one active or latent MTP. Treatment was performed in two phases: (1) four sessions (one session per week for four consecutive weeks) of placebo DN and (2) four sessions of therapeutic DN with a gap (washout) of 15 days between these phases. Results The Tinnitus Handicap Inventory (THI) variable and its emotional domain had a statistically significant reduction in therapeutic DN when compared with placebo DN (p = 0.024 and p = 0.011, respectively).The tinnitus visual analogic scale (VAS) signaled a reduction in tinnitus discomfort when compared with moments before and after therapeutic DN (p < 0.05). Conclusion The therapeutic DN technique for MTP in patients with chronic tinnitus of somatosensory origin proved effective in reducing symptom discomfort, as measured by the THI (total score) and its emotional domain when compared with placebo DN.

1 January 2019 in Revista CEFAC
Verified
Journal Article
Open access
PDF file
LGLaura Mochiatti Guijo
Laura Mochiatti Guijo
AFAngela Renata Sarambelli Fonseca
Angela Renata Sarambelli Fonseca
MHMirella Boaglio Horiuti
Mirella Boaglio Horiuti
LVLaura Garcia E. Vasconcelos
Laura Garcia E. Vasconcelos
ACAna Claudia Vieira Cardoso
Ana Claudia Vieira Cardoso
JOJeanne Oiticica
Jeanne Oiticica
Purpose: to review both the national and international literature as well as to describe the methods used to collect psychoacoustic measurements in tinnitus patients. Methods: the current integrative review was conducted on articles in specialized national and international journals, in both the Portuguese and English languages, available in the PubMed/Medline, BVS - LILACS and SCIELO databases. The following keywords and descriptors were used: hearing, tinnitus, psychoacoustic measurements, acuphenometry, and assessment, in both the Portuguese and English languages. The retrieved articles were read and selected for the review according to the eligibility criteria, which included the use of psychoacoustic measurements in tinnitus patients and the presence of a detailed methodological description of the protocol employed, in individuals with normal hearing and those with hearing loss. Results: a total of 12 articles, in which psychoacoustic measures were used for the characterization and the measurement of tinnitus in individuals with normal hearing and in those with hearing loss, were reviewed. The main findings were associated with the sample characterization and the way in which the psychoacoustic measures were performed. Conclusion:given the grouping of several protocols for tinnitus evaluation, which were determined following an integrative literature review, a great heterogeneity in the methods used to perform psychoacoustic measurements for tinnitus assessment for both clinical and scientific purposes was noted.

9 October 2023 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
JOJeanne Oiticica
Jeanne Oiticica
LVLaura G.E. Vasconcelos
Laura G.E. Vasconcelos
MHMirella B. Horiuti
Mirella B. Horiuti
Objective: This study investigated the effects of WN on LE in subjects with chronic tinnitus and normal hearing thresholds. The study was a prospective, non-randomized, before-and-after, intra-participant intervention. Methods: Twenty-five subjects performed the following tests: conventional and high-frequency audiometry, acuphenometry, screening questionnaires for depression and anxiety symptoms, Tinnitus Handicap Inventory (THI), Montreal Cognitive Assessment, and high WM test from the Working Memory Assessment Battery, Federal University of Minas Gerais (WMAB) as the LE measure in two conditions: No Added Noise (NAN) and with Added Noise (AN). Results: Seventeen participants (68%) performed better on AN condition. Data analysis revealed a 45% improvement in the WMAB total span count on AN setting, with a significant p value (p = 0.001). Conclusion: The subgroup of participants without traces of anxiety symptoms, up to mild traces of depressive symptoms, having unilateral tinnitus, and a THI level up to grade 2, had improved WM performance in the presence of WN, which suggests a release of cognitive resources and less auditory effort under these combined conditions. Evidence level: 4.

9 September 2026 in Clinics
Verified
Journal Article
Open access
EWElaine Miwa Watanabe
Elaine Miwa Watanabe
LVLaura G.E. Vasconcelos
Laura G.E. Vasconcelos
MBMaria F. Bonadia-Moraes
Maria F. Bonadia-Moraes
FHFatima T. Husain
Fatima T. Husain
NDNilo J.C. Duarte
Nilo J.C. Duarte
JOJeanne Oiticica
Jeanne Oiticica
Tinnitus is any perception of sound that occurs in the absence of an external auditory stimulus. Donepezil, commonly prescribed for dementia, has not yet been evaluated in individuals with tinnitus. By increasing synaptic availability of acetylcholine, a neurotransmitter widely distributed in the central nervous system and potentially neuroprotective against glutamate induced excitotoxicity, donepezil may offer a pharmacological approach for the management of this condition. We conducted a double-blind, prospective, randomized controlled trial with a sample of 35 each in a chronic subjective, non-somatosensory tinnitus group and an age- and gender-matched control group. Participants received either donepezil or a placebo for 3-months. Treatment effects were monitored using scales and questionnaires: THI, VAS, CDR, MMSE; and psychoacoustic measurements of tinnitus. No statistically significant difference in symptom improvement was observed between the donepezil and placebo groups as assessed by the evaluation instruments. Notably, analysis of confidence intervals for patients achieving a minimum improvement of ≥ 7 and ≥ 11-points in THI scores suggested a potential clinically meaningful trend favoring donepezil. Additionally, complete remission of tinnitus was observed in a single patient, occurring only in the donepezil group. In the present double-blind, randomized, placebo-controlled clinical trial, no statistically significant difference was identified between the groups regarding the primary outcome. However, the donepezil-treated group demonstrated better performance than the placebo group, and a possible indication of greater clinical benefit was observed in the treatment group in those using amplification, suggesting a potential therapeutic relevance, but larger, more in-depth studies are needed to confirm our findings.